Global Recombinant DNA Technology Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 15-Jul-2021
No. of pages: 122
Inquire Before Buying

Market Analysis and Insights: Global Recombinant DNA Technology Market

The global Recombinant DNA Technology market size is projected to reach US$ 644 million by 2027, from US$ 490.8 million in 2020, at a CAGR of 3.9% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant DNA Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant DNA Technology market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant DNA Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant DNA Technology market.

Global Recombinant DNA Technology Scope and Market Size

Recombinant DNA Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant DNA Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Therapeutic Agent

- Vaccine

- Biotech Crops

- Specialty Chemicals

Segment by Application

- Biotechnology and Pharmaceutical Companies

- Academic & Government Research Institutes

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Monsanto Company

- Roche

- Biogen

- Amgen

- Novartis

- Eli Lilly and Company

- GenScript

- Pfizer Inc.

- Novo Nordisk

- Sanofi

- Merck KGaA

- Profacgen

- Biocon

- GlaxoSmithKline

- Cibus

- Horizon Discovery Group

- New England Biolabs

Global Recombinant DNA Technology Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Therapeutic Agent
1.2.3 Vaccine
1.2.4 Biotech Crops
1.2.5 Specialty Chemicals
1.3 Market by Application
1.3.1 Global Recombinant DNA Technology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA Technology Market Perspective (2016-2027)
2.2 Recombinant DNA Technology Growth Trends by Regions
2.2.1 Recombinant DNA Technology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant DNA Technology Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant DNA Technology Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant DNA Technology Industry Dynamic
2.3.1 Recombinant DNA Technology Market Trends
2.3.2 Recombinant DNA Technology Market Drivers
2.3.3 Recombinant DNA Technology Market Challenges
2.3.4 Recombinant DNA Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA Technology Players by Revenue
3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2016-2021)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant DNA Technology Revenue
3.4 Global Recombinant DNA Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2020
3.5 Recombinant DNA Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA Technology Breakdown Data by Type
4.1 Global Recombinant DNA Technology Historic Market Size by Type (2016-2021)
4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2022-2027)
5 Recombinant DNA Technology Breakdown Data by Application
5.1 Global Recombinant DNA Technology Historic Market Size by Application (2016-2021)
5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Recombinant DNA Technology Market Size (2016-2027)
6.2 North America Recombinant DNA Technology Market Size by Type
6.2.1 North America Recombinant DNA Technology Market Size by Type (2016-2021)
6.2.2 North America Recombinant DNA Technology Market Size by Type (2022-2027)
6.2.3 North America Recombinant DNA Technology Market Size by Type (2016-2027)
6.3 North America Recombinant DNA Technology Market Size by Application
6.3.1 North America Recombinant DNA Technology Market Size by Application (2016-2021)
6.3.2 North America Recombinant DNA Technology Market Size by Application (2022-2027)
6.3.3 North America Recombinant DNA Technology Market Size by Application (2016-2027)
6.4 North America Recombinant DNA Technology Market Size by Country
6.4.1 North America Recombinant DNA Technology Market Size by Country (2016-2021)
6.4.2 North America Recombinant DNA Technology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Recombinant DNA Technology Market Size (2016-2027)
7.2 Europe Recombinant DNA Technology Market Size by Type
7.2.1 Europe Recombinant DNA Technology Market Size by Type (2016-2021)
7.2.2 Europe Recombinant DNA Technology Market Size by Type (2022-2027)
7.2.3 Europe Recombinant DNA Technology Market Size by Type (2016-2027)
7.3 Europe Recombinant DNA Technology Market Size by Application
7.3.1 Europe Recombinant DNA Technology Market Size by Application (2016-2021)
7.3.2 Europe Recombinant DNA Technology Market Size by Application (2022-2027)
7.3.3 Europe Recombinant DNA Technology Market Size by Application (2016-2027)
7.4 Europe Recombinant DNA Technology Market Size by Country
7.4.1 Europe Recombinant DNA Technology Market Size by Country (2016-2021)
7.4.2 Europe Recombinant DNA Technology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA Technology Market Size (2016-2027)
8.2 Asia-Pacific Recombinant DNA Technology Market Size by Type
8.2.1 Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant DNA Technology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant DNA Technology Market Size by Application
8.3.1 Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant DNA Technology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant DNA Technology Market Size by Region
8.4.1 Asia-Pacific Recombinant DNA Technology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant DNA Technology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant DNA Technology Market Size (2016-2027)
9.2 Latin America Recombinant DNA Technology Market Size by Type
9.2.1 Latin America Recombinant DNA Technology Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant DNA Technology Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant DNA Technology Market Size by Type (2016-2027)
9.3 Latin America Recombinant DNA Technology Market Size by Application
9.3.1 Latin America Recombinant DNA Technology Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant DNA Technology Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant DNA Technology Market Size by Application (2016-2027)
9.4 Latin America Recombinant DNA Technology Market Size by Country
9.4.1 Latin America Recombinant DNA Technology Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant DNA Technology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA Technology Market Size (2016-2027)
10.2 Middle East & Africa Recombinant DNA Technology Market Size by Type
10.2.1 Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant DNA Technology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant DNA Technology Market Size by Application
10.3.1 Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant DNA Technology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant DNA Technology Market Size by Country
10.4.1 Middle East & Africa Recombinant DNA Technology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant DNA Technology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Monsanto Company
11.1.1 Monsanto Company Company Details
11.1.2 Monsanto Company Business Overview
11.1.3 Monsanto Company Recombinant DNA Technology Introduction
11.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2016-2021)
11.1.5 Monsanto Company Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Recombinant DNA Technology Introduction
11.2.4 Roche Revenue in Recombinant DNA Technology Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Recombinant DNA Technology Introduction
11.3.4 Biogen Revenue in Recombinant DNA Technology Business (2016-2021)
11.3.5 Biogen Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Recombinant DNA Technology Introduction
11.4.4 Amgen Revenue in Recombinant DNA Technology Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Recombinant DNA Technology Introduction
11.5.4 Novartis Revenue in Recombinant DNA Technology Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
11.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2016-2021)
11.6.5 Eli Lilly and Company Recent Development
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Recombinant DNA Technology Introduction
11.7.4 GenScript Revenue in Recombinant DNA Technology Business (2016-2021)
11.7.5 GenScript Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
11.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2016-2021)
11.8.5 Pfizer Inc. Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Recombinant DNA Technology Introduction
11.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2016-2021)
11.9.5 Novo Nordisk Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Recombinant DNA Technology Introduction
11.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Recombinant DNA Technology Introduction
11.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2016-2021)
11.11.5 Merck KGaA Recent Development
11.12 Profacgen
11.12.1 Profacgen Company Details
11.12.2 Profacgen Business Overview
11.12.3 Profacgen Recombinant DNA Technology Introduction
11.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2016-2021)
11.12.5 Profacgen Recent Development
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Recombinant DNA Technology Introduction
11.13.4 Biocon Revenue in Recombinant DNA Technology Business (2016-2021)
11.13.5 Biocon Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
11.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2016-2021)
11.14.5 GlaxoSmithKline Recent Development
11.15 Cibus
11.15.1 Cibus Company Details
11.15.2 Cibus Business Overview
11.15.3 Cibus Recombinant DNA Technology Introduction
11.15.4 Cibus Revenue in Recombinant DNA Technology Business (2016-2021)
11.15.5 Cibus Recent Development
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Details
11.16.2 Horizon Discovery Group Business Overview
11.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
11.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2016-2021)
11.16.5 Horizon Discovery Group Recent Development
11.17 New England Biolabs
11.17.1 New England Biolabs Company Details
11.17.2 New England Biolabs Business Overview
11.17.3 New England Biolabs Recombinant DNA Technology Introduction
11.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2016-2021)
11.17.5 New England Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Therapeutic Agent
Table 3. Key Players of Vaccine
Table 4. Key Players of Biotech Crops
Table 5. Key Players of Specialty Chemicals
Table 6. Global Recombinant DNA Technology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Recombinant DNA Technology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Recombinant DNA Technology Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Recombinant DNA Technology Market Share by Regions (2016-2021)
Table 10. Global Recombinant DNA Technology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Recombinant DNA Technology Market Share by Regions (2022-2027)
Table 12. Recombinant DNA Technology Market Trends
Table 13. Recombinant DNA Technology Market Drivers
Table 14. Recombinant DNA Technology Market Challenges
Table 15. Recombinant DNA Technology Market Restraints
Table 16. Global Recombinant DNA Technology Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Recombinant DNA Technology Market Share by Players (2016-2021)
Table 18. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2020)
Table 19. Ranking of Global Top Recombinant DNA Technology Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Recombinant DNA Technology Product Solution and Service
Table 23. Date of Enter into Recombinant DNA Technology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Recombinant DNA Technology Revenue Market Share by Type (2016-2021)
Table 27. Global Recombinant DNA Technology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Recombinant DNA Technology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Recombinant DNA Technology Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Recombinant DNA Technology Revenue Market Share by Application (2016-2021)
Table 31. Global Recombinant DNA Technology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Recombinant DNA Technology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Recombinant DNA Technology Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Recombinant DNA Technology Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 63. Monsanto Company Company Details
Table 64. Monsanto Company Business Overview
Table 65. Monsanto Company Recombinant DNA Technology Product
Table 66. Monsanto Company Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 67. Monsanto Company Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Recombinant DNA Technology Product
Table 71. Roche Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Biogen Company Details
Table 74. Biogen Business Overview
Table 75. Biogen Recombinant DNA Technology Product
Table 76. Biogen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 77. Biogen Recent Development
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Recombinant DNA Technology Product
Table 81. Amgen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 82. Amgen Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Recombinant DNA Technology Product
Table 86. Novartis Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Eli Lilly and Company Company Details
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Recombinant DNA Technology Product
Table 91. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 92. Eli Lilly and Company Recent Development
Table 93. GenScript Company Details
Table 94. GenScript Business Overview
Table 95. GenScript Recombinant DNA Technology Product
Table 96. GenScript Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 97. GenScript Recent Development
Table 98. Pfizer Inc. Company Details
Table 99. Pfizer Inc. Business Overview
Table 100. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 101. Pfizer Inc. Recent Development
Table 102. Novo Nordisk Company Details
Table 103. Novo Nordisk Business Overview
Table 104. Novo Nordisk Recombinant DNA Technology Product
Table 105. Novo Nordisk Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 106. Novo Nordisk Recent Development
Table 107. Sanofi Company Details
Table 108. Sanofi Business Overview
Table 109. Sanofi Recombinant DNA Technology Product
Table 110. Sanofi Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 111. Sanofi Recent Development
Table 112. Merck KGaA Company Details
Table 113. Merck KGaA Business Overview
Table 114. Merck KGaA Recombinant DNA Technology Product
Table 115. Merck KGaA Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 116. Merck KGaA Recent Development
Table 117. Profacgen Company Details
Table 118. Profacgen Business Overview
Table 119. Profacgen Recombinant DNA Technology Product
Table 120. Profacgen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 121. Profacgen Recent Development
Table 122. Biocon Company Details
Table 123. Biocon Business Overview
Table 124. Biocon Recombinant DNA Technology Product
Table 125. Biocon Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 126. Biocon Recent Development
Table 127. GlaxoSmithKline Company Details
Table 128. GlaxoSmithKline Business Overview
Table 129. GlaxoSmithKline Recombinant DNA Technology Product
Table 130. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 131. GlaxoSmithKline Recent Development
Table 132. Cibus Company Details
Table 133. Cibus Business Overview
Table 134. Cibus Recombinant DNA Technology Product
Table 135. Cibus Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 136. Cibus Recent Development
Table 137. Horizon Discovery Group Company Details
Table 138. Horizon Discovery Group Business Overview
Table 139. Horizon Discovery Group Recombinant DNA Technology Product
Table 140. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 141. Horizon Discovery Group Recent Development
Table 142. New England Biolabs Company Details
Table 143. New England Biolabs Business Overview
Table 144. New England Biolabs Recombinant DNA Technology Product
Table 145. New England Biolabs Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 146. New England Biolabs Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA Technology Market Share by Type: 2020 VS 2027
Figure 2. Therapeutic Agent Features
Figure 3. Vaccine Features
Figure 4. Biotech Crops Features
Figure 5. Specialty Chemicals Features
Figure 6. Global Recombinant DNA Technology Market Share by Application: 2020 VS 2027
Figure 7. Biotechnology and Pharmaceutical Companies Case Studies
Figure 8. Academic & Government Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Recombinant DNA Technology Report Years Considered
Figure 11. Global Recombinant DNA Technology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Recombinant DNA Technology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Recombinant DNA Technology Market Share by Regions: 2020 VS 2027
Figure 14. Global Recombinant DNA Technology Market Share by Regions (2022-2027)
Figure 15. Global Recombinant DNA Technology Market Share by Players in 2020
Figure 16. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2020
Figure 18. Global Recombinant DNA Technology Revenue Market Share by Type (2016-2021)
Figure 19. Global Recombinant DNA Technology Revenue Market Share by Type (2022-2027)
Figure 20. North America Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 22. North America Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 23. North America Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 24. United States Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 28. Europe Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 29. Europe Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 30. Germany Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Recombinant DNA Technology Market Share by Region (2016-2027)
Figure 40. China Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 48. Latin America Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 49. Latin America Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 50. Mexico Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 56. Turkey Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 61. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 65. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 66. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 69. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 70. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 71. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 72. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 73. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 74. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 75. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
  • Global and China DNA Analysis in the Government Sector Market Size, Status and Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3900 Onwards        Pages: 109
    Global DNA Analysis in the Government Sector Scope and Market Size DNA Analysis in the Government Sector market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Analysis in the Government Sector market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for th......
  • Global Aptamers Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 20-Sep-2021        Price: US 3480 Onwards        Pages: 102
    The Aptamers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research, the ......
  • Global DNA Sequencing Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 20-Sep-2021        Price: US 3480 Onwards        Pages: 109
    The DNA Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research......
  • United States CRISPR and CRISPR-Associated (Cas) Genes Market Report & Forecast 2021-2027
    Published: 13-Sep-2021        Price: US 3400 Onwards        Pages: 108
    United States CRISPR and CRISPR-Associated (Cas) Genes Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States CRISPR and CRISPR-Associated (Cas) Genes Market Segment Percentages, By Type, 2020 (%) - Genome Editing - Genetic engineering - gRNA Database/Gene Librar - CRISPR Plasmid - Human Stem Cells - Genetically Modified Organisms/Crops - Cell Line Engineering United States CRISPR and CRISPR-Associated (Cas) Genes M......
  • United States DNA Sequencing Market Report & Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States DNA Sequencing Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States DNA Sequencing Market Segment Percentages, By Type, 2020 (%) - First Generation DNA Sequencing - Second Generation DNA Sequencing - Third Generation DNA Sequencing United States DNA Sequencing Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States DNA Sequencing Market Segment Percentages, By Application, 2020 (%)......
  • United States Aptamers Market Report & Forecast 2021-2027
    Published: 08-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Aptamers Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Aptamers Market Segment Percentages, By Type, 2020 (%) - DNA-Based Aptamers - RNA-Based Aptamers United States Aptamers Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Aptamers Market Segment Percentages, By Application, 2020 (%) - Research and Development - Drug Discovery Competitor Analysi......
  • China Whole Exome Sequencing Market Report & Forecast 2021-2027
    Published: 06-Sep-2021        Price: US 3400 Onwards        Pages: 91
    This report contains market size and forecasts of Whole Exome Sequencing in China, including the following market information: China Whole Exome Sequencing Market Revenue, 2016-2021, 2022-2027, ($ millions) China top five Whole Exome Sequencing companies in 2020 (%) The global Whole Exome Sequencing market size is expected to growth from US$ 264 million in 2020 to US$ 565.7 million by 2027; it is expected to grow at a CAGR of 11.4% during 2021-2027. The China Whole Ex......
  • Global and United States DNA Sequencing Market Insights, Forecast to 2027
    Published: 03-Sep-2021        Price: US 3900 Onwards        Pages: 135
    DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA. Global DNA Sequencing key players include Illumina, Roche, BGI, Pacific Biosciences, etc. Market Analysis and Insights: Global and United States DNA Sequencing Market This report focuses on global and United States DNA Sequencing market. In 2020, the global DNA Sequencing market size was US$ 13380 million and it is expected to reach......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 03-Sep-2021        Price: US 3480 Onwards        Pages: 127
    The Single Nucleotide Polymorphism (SNP) Genotyping market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs